SiSaf Announces Michael J. Econs MD, World-leading Expert in Metabolic Bone Disease, as Clinical Advisor
Guildford, England, 27 January 2022 – SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, today announced that it has appointed Professor Michael J. Econs, MD as Clinical Advisor.
Distinguished Professor of Medicine and Medical and Molecular Genetics at Indiana University School of Medicine, Professor Econs is director of the division of Endocrinology and Metabolism, and a world leading expert in the area of metabolic bone disease.
